Novel aryl(4-phenylpiperazin-1-yl)methanethione derivatives as new anti-Alzheimer agents: Design, synthesis, in vitro and in silico assays
Samira Ansari(Biotechnology Research Center), Parham Taslımı(Bartin University), Haleh Hamedifar(Biotechnology Research Center), Hojjat Rahmani(Tehran University of Medical Sciences), Mahmood Biglar(Tehran University of Medical Sciences), Ali Moazzam(Tehran University of Medical Sciences), Maryam Mohammadi‐Khanaposhtani(Babol University of Medical Sciences), Samanesadat Hosseini(Shahid Beheshti University of Medical Sciences), Hossein Adibi(Tehran University of Medical Sciences), Milad Noori(Iran University of Science and Technology), Mohammad Mahdavi(Shaheed Rajaei Cardiovascular Medical and Research Center), Bagher Larijani(Tehran University of Medical Sciences), Nastaran Sadeghian(Atatürk University), Keyvan Pedrood(Tehran University of Medical Sciences)
Cited by 7
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on α-glycosidase, α-amylase and human glutathione S-transferase enzymes
|International Journal of Biological Macromolecules|2018|215
Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors
|Bioorganic Chemistry|2019|202
Gut microbiota-derived metabolites in obesity: a systematic review
|Bioscience of Microbiota Food and Health|2020|178
The challenge for global health systems in preventing and managing obesity
|Obesity Reviews|2019|128